These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 25969634)
1. Imaging of lung cancer: Implications on staging and management. Purandare NC; Rangarajan V Indian J Radiol Imaging; 2015; 25(2):109-20. PubMed ID: 25969634 [TBL] [Abstract][Full Text] [Related]
2. CT, positron emission tomography, and MRI in staging lung cancer. Erasmus JJ; Sabloff BS Clin Chest Med; 2008 Mar; 29(1):39-57, v. PubMed ID: 18267183 [TBL] [Abstract][Full Text] [Related]
3. Role of positron emission tomography-computed tomography in non-small cell lung cancer. Garg PK; Singh SK; Prakash G; Jakhetiya A; Pandey D World J Methodol; 2016 Mar; 6(1):105-11. PubMed ID: 27018223 [TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761 [TBL] [Abstract][Full Text] [Related]
5. The impact of positron emission tomography on clinical decision making in a university-based multidisciplinary lung cancer practice. Sachs S; Bilfinger TV Chest; 2005 Aug; 128(2):698-703. PubMed ID: 16100156 [TBL] [Abstract][Full Text] [Related]
6. Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India. Nair S; Mohan S; Nilakantan A; Gupta A; Malik A; Gupta A World J Nucl Med; 2015; 14(1):19-24. PubMed ID: 25709540 [TBL] [Abstract][Full Text] [Related]
7. The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer. Volpi S; Ali JM; Tasker A; Peryt A; Aresu G; Coonar AS Ann Transl Med; 2018 Mar; 6(5):95. PubMed ID: 29666818 [TBL] [Abstract][Full Text] [Related]
8. Unexpected significant findings non-related to prostate cancer identified using combined prostate-specific membrane antigen positron emission tomography/CT and diagnostic CT scan in primary staging for prostate cancer. McEwan L; McBean R; Yaxley J; Wong D J Med Imaging Radiat Oncol; 2019 Jun; 63(3):318-323. PubMed ID: 30840361 [TBL] [Abstract][Full Text] [Related]
9. Imaging techniques for diagnosis and staging of lung cancer. McLoud TC Clin Chest Med; 2002 Mar; 23(1):123-36. PubMed ID: 11901907 [TBL] [Abstract][Full Text] [Related]
10. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3. Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer. Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440 [TBL] [Abstract][Full Text] [Related]
12. Dilemmas in Lung Cancer Staging. Vlahos I Radiol Clin North Am; 2018 May; 56(3):419-435. PubMed ID: 29622077 [TBL] [Abstract][Full Text] [Related]
13. 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review. Ung YC; Maziak DE; Vanderveen JA; Smith CA; Gulenchyn K; Lacchetti C; Evans WK; J Natl Cancer Inst; 2007 Dec; 99(23):1753-67. PubMed ID: 18042932 [TBL] [Abstract][Full Text] [Related]
14. The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer. Vesselle H; Pugsley JM; Vallières E; Wood DE J Thorac Cardiovasc Surg; 2002 Sep; 124(3):511-9. PubMed ID: 12202868 [TBL] [Abstract][Full Text] [Related]
16. Positron Emission Tomography Computed Tomography: A Guide for the General Radiologist. Beadsmoore C; Newman D; MacIver D; Pawaroo D Can Assoc Radiol J; 2015 Nov; 66(4):332-47. PubMed ID: 26277234 [TBL] [Abstract][Full Text] [Related]
17. Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non-Small Cell Lung Cancer. Kandathil A; Kay FU; Butt YM; Wachsmann JW; Subramaniam RM Radiographics; 2018; 38(7):2134-2149. PubMed ID: 30422775 [TBL] [Abstract][Full Text] [Related]
18. Lung cancer staging now and in the future. Liam CK; Andarini S; Lee P; Ho JC; Chau NQ; Tscheikuna J Respirology; 2015 May; 20(4):526-34. PubMed ID: 25682805 [TBL] [Abstract][Full Text] [Related]
19. Oligometastatic non-small cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan era. De Pas TM; de Braud F; Catalano G; Putzu C; Veronesi G; Leo F; Solli PG; Brambilla D; Paganelli G; Spaggiari L Ann Thorac Surg; 2007 Jan; 83(1):231-4. PubMed ID: 17184669 [TBL] [Abstract][Full Text] [Related]
20. Endobronchial ultrasound-guided transbronchial needle aspiration for systematic nodal staging of lung cancer in patients with N0 disease by computed tomography and integrated positron emission tomography-computed tomography. Ong P; Grosu H; Eapen GA; Rodriguez M; Lazarus D; Ost D; Jimenez CA; Morice R; Bandi V; Tamara L; Cornwell L; Green L; Zhu A; Casal RF Ann Am Thorac Soc; 2015 Mar; 12(3):415-9. PubMed ID: 25584815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]